The tricuspid valve is rarely affected by myocardial infarction. The right ventricle has a lower systolic pressure compared to the left ventricle making the papillary muscles of the tricuspid valve more resistant to ischemia. The right coronary artery is the main blood supply to tricuspid papillary muscles, chordae rupture of the tricuspid valve may occur following myocardial infarction. Here, we present a rare case of a 70-year-old male with severe tricuspid regurgitation, a completely occluded right coronary artery (RCA), 70% stenosis of the left main coronary artery (LMCA), and 100% occlusion of the left anterior descending artery (LAD). The patient’s ejection fraction (EF) was reduced to 30%. Treatment included tricuspid valve repair using the bicuspidization technique and a five-vessel coronary artery bypass graft (CABG). This case demonstrates that, although rare, myocardial infarction can involve the tricuspid valve and that the surgery of the valve with full revascularization proved to be an effective treatment strategy in our patient.
Restrictive cardiomyopathy (RCM) is associated with a high mortality rate among patients awaiting heart transplantation, largely due to the challenges inherent in mechanical circulatory support device implantation and the limited effectiveness of pharmacologic therapies. The small size of the left ventricular cavity in RCM patients can cause significant complications, such as inflow cannula obstruction, impaired diastolic filling, and an increased risk of suction events. Here, we present 2 cases, each rare individually, both of which posed unique surgical challenges. Our aim was to evaluate the preoperative conditions, clinical characteristics, surgical approaches, and early outcomes in 2 RCM patients: one who received a left ventricular assist device (LVAD) as a bridge to heart transplantation, and the other as a bridge to candidacy. For the first patient, LVAD implantation with mitral valve resection was performed under emergency conditions due to the presence of a left atrial thrombus; subsequent heart transplantation was later achieved. For the second patient, LVAD implantation with mitral valve replacement was conducted as a bridge to candidacy in the setting of high pulmonary vascular resistance.